MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Movement disorders with phosphodiesterase 10A IgG autoimmunity

    C. Valencia-Sanchez, A. Mckeon, A. Zekeridou (Scottsdale, USA)

    Objective: To report four new cases of phosphodiesterase 10A (PDE10A) IgG neurological autoimmunity. Background: PDE10A IgG was recently identified as a biomarker of paraneoplastic neurological…
  • 2022 International Congress

    Quantity detection of Substantia nigra hyperechogenicity based on digital image analysis for diagnosing Parkinson’s disease

    L. Gao, Z. Xue, X. Zhou (Nanchang, China)

    Objective: We aimed to apply digital analysis to quantify hyperechogenicity of Substantia nigra, and explore its clinical value for the diagnosis of PD. Background: Increased…
  • 2022 International Congress

    Testamentary Capacity Assessment Tool (TCAT): An update report

    P. Voskou, A. Douzenis, A. Economou, S. Papageorgiou (Athens, Greece)

    Objective: The present study reviews all studies about TCAT and its use in clinical settings, as well as its validation in different cultures. Background: TCAT…
  • 2022 International Congress

    SARS-CoV-2 Infection and Spinocerebellar Ataxia 12: Demographics, Outcomes and Post- COVID Spectrum

    IS. Singh, VS. Swarup, AKS. Srivastava (New Delhi, India)

    Objective: We aimed to assess the symptoms and long-term symptoms in spinocerebellar ataxia 12 (SCA12) COVID-19 patients. Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
  • 2022 International Congress

    Neurofilament light chain protein (NfL) is elevated in Essential Tremor

    S. Franthal, M. Khalil, L. Pirpamer, A. Buchmann, P. Katschnig-Winter, M. Koegl-Hammer, N. Homayoon, K. Wenzel, R. Schmidt, P. Schwingenschuh (Graz, Austria)

    Objective: To investigate neurofilament light chain protein (sNfL) concentrations in serum in Essential Tremor (ET) compared to healthy controls and to assess whether sNfL is…
  • 2022 International Congress

    Discrepancies in postural stability outcomes measured by computerized dynamic posturography and functional balance assessments in Parkinson’s Disease

    E. Doctor, R. Bliss, J. Kanaley (Columbia, USA)

    Objective: To determine ideal assessment for detecting exercise-induced differences in postural stability of individuals with early-stage Parkinson’s Disease (PD). Background: Postural instability (PI) is a…
  • 2022 International Congress

    Validation of Direct/Indirect targets with intra-operative clinical assessment in the Indian population & comparison with image guided and MER based targeting for Subthalamic Nucleus(STN) based Deep Brain Stimulation(DBS) in Parkinson’s disease(PD)

    A. Uppar, D. Srinivas, R. Yadav, P. Pal, V. Holla (BANGALORE, India)

    Objective: This study attempts to validate the relationship between Direct-D, indirect-ID coordinates for STN in Indian subjects.  Also, this study tries to compare the D,…
  • 2022 International Congress

    A phase 2b, randomized, dose-response study of SAGE-324/BIIB124 for the treatment of essential tremor: KINETIC 2 trial in progress

    R. Pahwa, A. Ellenbogen, R. Elble, K. Bankole, T. Dam, J. Fratantonio, J. Gaiha-Rohrbach, M. Qin, S. Garafola, M. Gerbasi, H. Colquhoun (Kansas City, USA)

    Objective: The phase 2b KINETIC 2 trial is a double-blind, randomized, placebo-controlled, dose-response study designed to evaluate SAGE-324/BIIB124 (SAGE-324) for the treatment of patients with…
  • 2022 International Congress

    Implementing Team-Based Outpatient Palliative Care in Parkinson’s Foundation Centers of Excellence (COE): Study Design

    M. Dini, S. Seshadri, S. Norton, J. Holtrop, P. Auinger, N. Yarab, B. Kluger (New York, USA)

    Objective: To describe the study design and early lessons of an implementation project aiming to make integrated palliative care (PC) a new standard of care…
  • 2022 International Congress

    Evaluation of Atrophy after Botulinum Toxin injection for Cervical Dystonia by MRI

    M. Salari, M. Etemadifar, S. Parvizi (Tehran, Islamic Republic of Iran)

    Objective: Cervical Dystonia (CD) is the most common form of focal dystonia involving the muscles of the neck and sometimes the shoulders. 1 There are several categories…
  • « Previous Page
  • 1
  • …
  • 504
  • 505
  • 506
  • 507
  • 508
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley